SAM
CORT icon

Synergy Asset Management’s Corcept Therapeutics CORT Stock Holding History

Synergy Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-506,856
Closed -$39.6M – 241
2025
Q3 		$39.6M Buy
506,856
+248,362
+96% +$18M 1.43% 17
2025
Q2 		$19M Buy
258,494
+87,743
+51% +$6.36M 2.17% 17
2025
Q1 		$19.5M Sell
170,751
-291,660
-63% -$17.8M 2.46% 10
2024
Q4 		$22.4M Buy
462,411
+262,503
+131% +$13.8M 1.73% 14
2024
Q3 		$9.25M Buy
199,908
+193,156
+2,861% +$6.86M 1.41% 16
2024
Q2 		$219K Buy
+6,752
New +$185K 0.03% 124

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Synergy Asset Management's CORT Position: Q4 2025 in Review

Synergy Asset Management sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 506,856 shares — an estimated $39.6M sold.

Synergy Asset Management first reported a position in CORT in Q2 2024 and held it in 6 quarters. The position peaked at $39.6M in Q3 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Synergy Asset Management reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Synergy Asset Management sold 506,856 Corcept Therapeutics shares in Q4 2025, an estimated $39.6M.
  • Synergy Asset Management first reported a position in Corcept Therapeutics in Q2 2024 and held it in 6 quarters.
  • Synergy Asset Management's Corcept Therapeutics position peaked at $39.6M in Q3 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Synergy Asset Management's 13F filing for Q4 2025, filed 13 Jan 2026.